(Total Views: 53)
Posted On: 08/19/2025 8:19:38 AM
Post# of 145322

$CVM CEL-SCI to sign partnership agreement in Saudi Arabia—Potential for patient access and reimbursement/sale of Multikine in Saudi Arabia within approximately 60 days following filing for Breakthrough Medicine Designation
https://www.businesswire.com/news/home/202508...al-Results
https://www.businesswire.com/news/home/202508...al-Results

